Upstream Processing

BeiGene adopts GE ‘turnkey’ factory for anti-PD-1 mAb production

25-Sep-2018 By Flora Southey

BeiGene will use GE Healthcare Life Sciences’ ‘off-the-shelf’ factory to manufacture monoclonal antibodies in Guangdong Province, China.

CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic

24-Sep-2018 By Flora Southey

Dyadic’s CHO-alternative, the C1 production platform, could reduce time and cost at almost every stage of the cell development and biomanufacturing process, says CEO.

TriLink BioTechnologies to relocate to expand operations

21-Sep-2018 By Maggie Lynch

TriLink BioTechnologies, a subsidiary of Maravai, that provides gene therapy services to researchers, has announced it will relocate to expand the company’s operations.

Q&A

Plant-derived rituximab? iBio inks ‘green’ bioreactor tech deal in China

10-Sep-2018 By Flora Southey

iBio has partnered with CC-Pharming to develop and manufacture a monoclonal antibody using whole plants.

BiondVax expands manufacturing capabilities for universal flu vaccine

04-Sep-2018 By Ben Hargreaves

BiondVax moved into a new facility with an increased capacity of 40 million doses per year ahead of potential approval for its universal flu vaccine.

ABEC to supply China’s ‘rapidly growing’ biopharma industry from Ireland

28-Aug-2018 By Flora Southey

China has accredited ABEC to make and supply bioprocessing equipment from its Kells facility in Ireland.

Standardised mAb production research provides ‘benchmark’ for biosimilars

22-Aug-2018 By Ben Hargreaves

NIST has progressed beyond producing the world’s first standardised mAb to make public its production methods.

Amgen begins work on $200m ‘next-gen’ biomanufacturing site

10-Aug-2018 By Ben Hargreaves

Amgen has broken ground on the construction of its West Greenwich, Rhode Island-based 120,000-square-foot biomanufacturing facility.

Algenuity develops green solution for pharma with algae platform

07-Aug-2018 By Ben Hargreaves

Algenuity has launched the MERIT project to develop renewable methods of producing therapeutic agents.

US FDA puts gene-therapy on hold after DNA fragment found in plasmids

27-Jul-2018 By Maggie Lynch

Sarepta’s gene therapy clinical trial is put on hold by the US FDA after DNA fragment was found in plasmids during quality assurance testing.

Catalent brings in Berkeley Lights to optimise cell lines

18-Jul-2018 By Ben Hargreaves

Catalent has agreed a deal to apply Berkeley Lights’ Beacon optofluidic platform to its cell lines.

NEWS IN BRIEF

Selexis and Symphogen expand partnership to progress two mAbs

11-Jul-2018 By Ben Hargreaves

Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexis’ platform.

Pluristem brings in Thermo Fisher to ‘transform cell therapy manufacturing’

11-Jul-2018 By Ben Hargreaves

Pluristem Therapeutics has announced that it has agreed a strategic collaboration with Thermo Fisher to improve the process by which cell therapies are manufactured.

Abzena signs $5.9m manufacture agreement with Telix

04-Jul-2018 By Ben Hargreaves

Abzena has revealed that it has signed a GMP manufacturing and bioconjugation deal with Telix worth $5.9m.

Entegris: Growing demand for single-use tech drives Flex Concepts buy

03-Jul-2018 By Flora Southey

Entegris says buying Flex Concepts will help secure its supply of disposable bioprocessing bags and fluid transfer technologies.